Stewart Gaede - Concepedia

Author

Stewart Gaede

Western University ORCID

Also Known As

F Prato, S Gaede, S. D. Gaede, S. Gaede, Stewart Gaede

183

Publications

5.8K

Citations

H-Index

Concepts

All Affiliations

Western University London Health Sciences Centre Cancer Care Ontario Sunnybrook Health Science Centre Lawson Health Research Institute

About

Stewart Gaede is an author at Western University specializing in radiology, medicine, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	13	14	2.4K
2	Health Sciences	12	13	2.4K
3	Engineering	10	10	329
4	Biomedical Engineering	5	5	121
5	Biostatistics	4	4	202

Stewart Gaede

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial David A. Palma, Robert Olson, Stephen Harrow, The Lancet Open-label TrialRadiation TherapyMedicineOligometastatic CancersStereotactic Ablative Radiotherapy	2019	1.8K
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial David A. Palma, Robert Olson, Stephen Harrow, Journal of Clinical Oncology	2020	1.2K
Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): Study protocol for a randomized phase II trial David A. Palma, Cornelis J.A. Haasbeek, George Rodrigues, BMC Cancer	2012	306
Stereotactic ablative radiotherapy for the comprehensive treatment of 4–10 oligometastatic tumors (SABR-COMET-10): study protocol for a randomized phase III trial David A. Palma, Robert Olson, Stephen Harrow, BMC Cancer	2019	250
Stereotactic Radiation for the Comprehensive Treatment of Oligometastases (SABR-COMET): Extended Long-Term Outcomes Stephen Harrow, David A. Palma, Robert Olson, International Journal of Radiation OncologyBiologyPhysics Comprehensive TreatmentRadiation MedicineRadiopharmaceutical TherapyStereotactic RadiationRadiation Oncology	2022	189
Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial David A. Palma, Robert Olson, Stephen Harrow, Surgical OncologyCancer ManagementOligometastatic CancersTreatment VerificationNeuro-oncology	2020	130
Inter-observer and intra-observer reliability for lung cancer target volume delineation in the 4D-CT era Alexander V. Louie, George Rodrigues, Jason Olsthoorn, Radiotherapy and Oncology Computed TomographyEngineeringMedical ImagingMedicineMultiple Pulmonary Nodule	2010	116
Stereotactic ablative radiotherapy for the comprehensive treatment of 1–3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial Robert Olson, Lindsay Mathews, Mitchell Liu, BMC Cancer	2020	115
Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial David A. Palma, Robert Olson, Stephen Harrow, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyComprehensive TreatmentSurgical OncologyRadiation MedicineOligometastatic Tumors	2018	107
Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non–Small Cell Lung Cancer David A. Palma, Timothy K. Nguyen, Alexander V. Louie, JAMA Oncology	2019	85

Page 1